Neoplasias benignas e malignas em 261 necropsias de pacientes HIV positivos no período de 1989 a 2008

Considering that there are some studies with autopsies from AIDS describing only malignant neoplasias and that changes can occur after the introduction of Highly Active Antiretroviral Therapy (HAART), our objectives were to analyze the frequency of benign and malignant neoplasms in AIDS patients in the periods of both pre- and post-HAART. This is a retrospective study with 261 autopsies of HIV-positive patients between 1989 and 2008 in Uberaba, Brazil. Sixty-six neoplasms were found (39 benign, 21 malignant and six premalignant) in 58 patients. The most frequent malignant neoplasms were lymphoid, in 2.7% (four Non-Hodgkin lymphoma, one Hodgkin, one multiple myeloma and one plasmablastic plasmacytoma), and Kaposi's Sarcoma, in 2.3% (six cases). The most frequent benign neoplasms were hepatic hemangiomas in 11 (4.2%) of 261 cases and uterine leiomyoma in 11 (15.7%) of 70 woman. In the pre-HAART period eight (9.8%) benign neoplasias and four (4.9%) malignant occurred in 82 patients; in the post-HAART period, 29 (16.2%) benign and 17 (9.5%) malignant were present; however, the differences were not significant. We conclude that the introduction of HAART in our region doesn't look to have modified the frequency of neoplasms occurring in patients with HIV.Tendo em vista que trabalhos sobre necropsias de AIDS analisam apenas neoplasias malignas e que ocorreram alterações após a terapia antiretroviral altamente eficaz (HAART), este estudo foi feito com objetivo de avaliar a frequência de neoplasias benignas e malignas nos períodos pré e pós-HAART. Estudo retrospectivo de 261 necropsias de HIV positivos entre 1989 e 2008 em Uberaba - Brasil. Foram encontradas 66 neoplasias (39 benignas, 21 malignas e seis lesões pré-invasivas) em 58 pacientes. As neoplasias malignas mais frequentes foram linfóides, em 2,7% (quatro linfomas não Hodgkin, um Hodgkin, um mieloma múltiplo e um plasmocitoma plasmoblástico) e, sarcoma de Kaposi, em 2,3% (seis casos). As benignas mais frequentes foram hemangiomas hepáticos em 11 (4,2%) dos 261 casos e leiomiomas uterinos em 11 (15,7%) das 70 mulheres. No período pré-HAART ocorreram oito (9,8%) neoplasias benignas e quatro (4,9%) malignas em 82 pacientes; no pós-HAART, 29 (16,2%) benignas e 17 (9,5%) malignas; entretanto, essas diferenças não foram estatisticamente significantes. Concluímos que a introdução da HAART em nossa região não parece ainda ter alterado a frequência de neoplasias em pacientes HIV

Morphological changes in the digestive system of 322 necropsies of patients with acquired immune deficiency syndrome: comparison of findings pre- and post-HAART (Highly Active Antiretroviral Therapy)

Involvement of the digestive system in AIDS pathologies or injuries is frequent. Aiming at comparing the frequency, the importance that these lesions have for death and the survival time in patients using or not using HAART, we studied 322 necropsies classified as follows: Group A - without antiretroviral drugs (185 cases); B - one or two antiretroviral drugs or HAART for less than six months (83 cases); C - HAART for six months or longer (54 cases). In the overall analysis of the digestive system, changes were present in 73.6% of cases. The most frequent was Candida infection (22.7%), followed by cytomegalovirus (19.2%), Histoplasma capsulatum (6.5%), mycobacteria (5.6%), and Toxoplasma gondii (4.3%). T. gondii infection was more frequent in group A compared with group C, and cytomegalovirus (CMV) was more frequent in group A compared with groups B and C (p < 0.05); 2.2% of the deaths were due to gastrointestinal bleeding. Regarding the segments, only in the large intestine, and only cytomegalovirus, were more frequent in group A compared with group C. We conclude that digestive system infections are still frequent, even with the use of HAART. However, the average survival time in group C was more than three times greater than the one in group A and nearly double that of group B, demonstrating the clear benefit of this therapy

Desenvolvimento motor de crianças pré-termo moderadas aos sete e oito anos de idade

Preterm children may have light motor developmental impairments, which may be imperceptible until pre-school age or even school age. The aim of this study was to compare the motor development of moderate preterm children with full-term ones at seven and eight years of age. Data from 13 preterm and 13 full-term children were collected from a public school in Betim-MG. The Motor Development Scale was used to access fine and global motricity, balance, body scheme, spatial organization, time organization, as well as general motor age and general motor quotient. The Mann-Whitney's Test was used to compare the motor ages and motor quotients between the groups. A significant difference was only found in the fine motricity values between the groups (p=0.01), the preterm group having shown a poorer performance. Therefore, moderate preterm children who do not have highly risky biological characteristics at birth may also need outpatient assistance up to school age.Crianças pré-termo podem apresentar distúrbios leves do desenvolvimento motor, que podem ser imperceptíveis até a idade pré-escolar ou escolar. O objetivo desse estudo foi comparar o desenvolvimento motor de crianças pré-termo moderadas com crianças a termo aos sete e oito anos de idade. Foram coletados dados de 13 crianças pré-termo e 13 crianças a termo de uma escola da rede municipal de Betim. Foi utilizada a Escala de Desenvolvimento Motor para avaliar motricidade fina, motricidade global, equilíbrio, esquema corporal, organização espacial e organização temporal, bem como a idade motora geral e o quociente motor geral. O teste Mann-Whitney foi utilizado para comparar as idades motoras e os quocientes motores entre os grupos. Foi encontrada diferença significativa somente nos valores da motricidade fina entre os grupos (p=0,01), sendo que o grupo pré-termo apresentou desempenho inferior. Dessa forma, crianças pré-termo moderadas que não apresentam características de alto risco biológico ao nascimento também podem necessitar de acompanhamento ambulatorial até a idade escolar

The challenges in the application of educational strategies for doctors in the Programa Mais Médicos do Brasil (PMMB): An analytical-descriptive study

This article analyzes the challenges faced for the application of educational strategies for physicians in the Programa Mais Médicos of Brasil (“More Physicians”) and the contributions of these professionals to the work processes of Family Health teams with a focus on achieving comprehensiveness of health care and the expansion of health care. access to hard-to-reach regions. It is a documentary analysis of a descriptive nature, which includes from laws and regulations, norms, opinions, letters, memo, personal diaries, autobiographies, newspapers, magazines, speeches, radio and television program scripts to books, statistics and files schoolchildren. The results indicate that there is a need for dynamic flexibility in educational actions, focusing on the needs of the population and regions that host the program to reduce care inequities and favor the strengthening of bonds between staff and users in order to provide comprehensive care . Among the challenges, we can highlight the program\u27s contribution to the reduction of practices segmented by professional categories, subordinated to the (bio)medical figure and knowledge, with limited interprofessional and team-community interaction in the construction of common care and interconstitutive knowledge. However, it could be concluded that the contribution of the doctors of the “Mais Médicos” Program in Brazil, in addition to reducing inequities and expanding access to healthcare for the population, also contributes to the deconstruction of the hegemonic medical model, taking into account the importance of interdisciplinary knowledge for the success of comprehensive health care. In addition, it reiterates the importance of dynamic actions focusing on local and territorial reality for educational strategies, as territories have peculiar characteristics, developing the critical-reflective process of professionals and capable of solving demands in different regions

Interferência da Amiodarona no metabolismo dos hormônios tireoidianos

Objetivo: Verificar as possíveis causas de tireoidopatia associada à amiodarona. Revisão bibliográfica: A grande quantidade de iodo na sua composição, inibição das deiodinases, bloqueio da captação dos hormônios tireoidianos, citotoxicidade e a redução da conexão da triiodotironina (T3) ao receptor são as principais alterações descritas causada pela amiodarona. Os estudos selecionados sugerem que a amiodarona tem um potencial inibidor das atividades enzimáticas deiodinases do tipo 1 e 2, dificultando a entrada de hormônios tireoidianos nos tecidos por antagonismo. Este incremento de iodo liberado pelo fármaco inibe a síntese e secreção dos hormônios tireoidianos, proporcionando adaptação à sobrecarga no hipotireoidismo. O hipertireoidismo induzido pela amiodarona divide-se em tipo I, sendo um efeito da produção e liberação excessiva de hormônios tireoidianos induzidos pelo alto teor de iodo, exacerbando a autoimunidade. No tipo II o excesso de hormônio é resultado de uma tireoidite destrutiva, com um processo de liberação de hormônios pré-formados do colóide. Considerações finais: Disfunções tireoidianas podem ocorrer pelo elevado potencial da amiodarona em modular a homeostase de iodo. Deve-se realizar dosagens frequentes de TSH, T4L e anticorpos antitireoidianos, avaliando a função tireoidiana periodicamente, sendo importante avaliar a suspensão deste medicamento, tendo em vista a adaptação cardioendócrina

SABER TREINAR A SI MESMO: PORQUE E COMO DEVEMOS ENSINAR TREINAMENTO NAS AULAS DE EDUCAÇÃO FÍSICA?

O texto apresenta argumentações cientificas sobre o treino corporal na escola a partir de uma experiência concreta na Escola Municipal Teodoro Sampaio, Salvador, Bahia, Brasil

Neurostimulation Combined With Cognitive Intervention in Alzheimer’s Disease (NeuroAD): Study Protocol of Double-Blind, Randomized, Factorial Clinical Trial

Despite advances in the treatment of Alzheimer’s disease (AD), there is currently no prospect of a cure, and evidence shows that multifactorial interventions can benefit patients. A promising therapeutic alternative is the use of transcranial direct current stimulation (tDCS) simultaneously with cognitive intervention. The combination of these non-pharmacological techniques is apparently a safe and accessible approach. This study protocol aims to compare the efficacy of tDCS and cognitive intervention in a double-blind, randomized and factorial clinical trial. One hundred participants diagnosed with mild-stage AD will be randomized to receive both tDCS and cognitive intervention, tDCS, cognitive intervention, or placebo. The treatment will last 8 weeks, with a 12-month follow-up. The primary outcome will be the improvement of global cognitive functions, evaluated by the AD Assessment Scale, cognitive subscale (ADAS-Cog). The secondary outcomes will include measures of functional, affective, and behavioral components, as well as a neurophysiological marker (Brain-derived neurotrophic factor, BDNF). This study will enable us to assess, both in the short and long term, whether tDCS is more effective than the placebo and to examine the effects of combined therapy (tDCS and cognitive intervention) and isolated treatments (tDCS vs. cognitive intervention) on patients with AD.Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT02772185—May 5, 2016

Pervasive gaps in Amazonian ecological research

Biodiversity loss is one of the main challenges of our time,1,2 and attempts to address it require a clear un derstanding of how ecological communities respond to environmental change across time and space.3,4 While the increasing availability of global databases on ecological communities has advanced our knowledge of biodiversity sensitivity to environmental changes,5–7 vast areas of the tropics remain understudied.8–11 In the American tropics, Amazonia stands out as the world’s most diverse rainforest and the primary source of Neotropical biodiversity,12 but it remains among the least known forests in America and is often underrepre sented in biodiversity databases.13–15 To worsen this situation, human-induced modifications16,17 may elim inate pieces of the Amazon’s biodiversity puzzle before we can use them to understand how ecological com munities are responding. To increase generalization and applicability of biodiversity knowledge,18,19 it is thus crucial to reduce biases in ecological research, particularly in regions projected to face the most pronounced environmental changes. We integrate ecological community metadata of 7,694 sampling sites for multiple or ganism groups in a machine learning model framework to map the research probability across the Brazilian Amazonia, while identifying the region’s vulnerability to environmental change. 15%–18% of the most ne glected areas in ecological research are expected to experience severe climate or land use changes by 2050. This means that unless we take immediate action, we will not be able to establish their current status, much less monitor how it is changing and what is being lostinfo:eu-repo/semantics/publishedVersio